XPNPEP2: A Potential Drug Target and Biomarker for Membrane-bound Aminopeptidases

Target Name: XPNPEP2

NCBI ID: G7512

XPNPEP2

XPNPEP2: A Potential Drug Target and Biomarker for Membrane-bound Aminopeptidases

Introduction

Membrane-bound aminopeptidases (MBAPs) are a diverse family of enzymes that play a crucial role in various cellular processes. These enzymes belong to the superfamily of ATP-binding cassette (ABC) proteins, and are involved in the intracellular signaling pathway known as the TOR signaling pathway. MBAPs are involved in the regulation of various cellular processes, including cell growth, apoptosis, angiogenesis, and inflammation.

Recent studies have identified XPNPEP2, a novel membrane-bound Aminopeptidase (AP) that is expressed in various tissues and organs, as a potential drug target and biomarker. In this article, we will provide an overview of XPNPEP2, its functions, and potential as a drug target.

FUNCTIONS OF XPNPEP2

XPNPEP2 is a 26-kDa protein that is expressed in various tissues and organs, including liver, kidney, heart, and pancreas. It is a member of the MBAP family and is involved in the regulation of various cellular processes.

XPNPEP2 is involved in the regulation of cell growth and apoptosis. It has been shown to promote the growth of cancer cells and to contribute to their survival. In addition, XPNPEP2 has been shown to induce cell apoptosis in various cell types, including liver cancer, breast cancer, and neuroblastoma.

XPNPEP2 is also involved in the regulation of angiogenesis. It has been shown to promote the formation of new blood vessels in various tissues and organs, including the liver and the kidneys. This process is crucial for the development and maintenance of tissues and organs, and is often disrupted in diseases such as diabetes and hypertension.

In addition to its role in cellular signaling, XPNPEP2 has also been shown to play a role in the regulation of inflammation. It has been shown to contribute to the development of various inflammatory diseases, including arthritis and asthma.

POTENTIAL AS A DRUG TARGET

The identification of XPNPEP2 as a potential drug target has led to the development of various compounds that have been shown to inhibit its activity. These compounds have been shown to have a variety of therapeutic effects, including the inhibition of cancer cell growth, the inhibition of angiogenesis, and the inhibition of inflammation.

In addition to its potential therapeutic effects, XPNPEP2 also has the potential to serve as a biomarker for various diseases. The expression of XPNPEP2 has been shown to be associated with the development of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.

CONCLUSION

In conclusion, XPNPEP2 is a novel membrane-bound Aminopeptidase that is involved in various cellular processes. Its functions include the regulation of cell growth, apoptosis, angiogenesis, and inflammation. The identification of XPNPEP2 as a potential drug target and biomarker has led to the development of various compounds that have been shown to inhibit its activity. Further research is needed to fully understand the role of XPNPEP2 in cellular processes and its potential as a drug target and biomarker.

Protein Name: X-prolyl Aminopeptidase 2

Functions: Membrane-bound metalloprotease which catalyzes the removal of a penultimate prolyl residue from the N-termini of peptides, such as Arg-Pro-Pro. May play a role in the metabolism of the vasodilator bradykinin

The "XPNPEP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about XPNPEP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets